Utilisation and Safety of Asenapine in Secondary Care in the UK: Results from the Observational Safety Evaluation of Asenapine (OBSERVA) Study

被引：0
|
作者：
Dhanda, S. [1 ,2 ]
Slade, J. [1 ]
Obsorne, V. [1 ]
Wise, L. [1 ]
Shakir, S. [1 ,2 ]
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
[2] Univ Portsmouth, Portsmouth, Hants, England
来源：
DRUG SAFETY | 2018年 / 41卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
ISoP18-106
引用
收藏
页码：1129 / 1130
页数：2
相关论文
共 50 条
  • [31] Effectiveness and safety of secondary prophylaxis with rFVIIa in haemophilia patients with inhibitors: results from the pro-pact observational study
    Blanchette, V. S.
    Santagostino, E.
    Morfini, M.
    Auerswald, G. K.
    Lambert, T.
    Jimenez-Yuste, V
    Young, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 511 - 511
  • [32] Efficacy and Safety of HP-3070, an Asenapine Transdermal System, in Patients With Schizophrenia: A Phase 3, Randomized, Placebo-Controlled Study
    Citrome, Leslie
    Walling, David P.
    Zeni, Courtney M.
    Starling, Brittney R.
    Terahara, Takaaki
    Kuriki, Masaaki
    Park, Alexandra S.
    Komaroff, Marina
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (01)
  • [33] Evaluation of the efficacy and safety of belimumab and telitacicept in patients with systemic lupus erythematosus: results from a retrospective, observational study
    Feng, Tianxiao
    Zhang, Manyu
    Wang, Jieying
    Li, Yang
    Cui, Yang
    CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
  • [34] A Comparative Study of Efficacy and Safety of Three Atypical Antipsychotic Agents: Asenapine, Ziprasidone and Clozapine in Indian Schizophrenic Patients: A Randomized Controlled Trial
    Dutta, Trayambak
    Bhowmick, Subhrojyoti
    Mitra, Minakshi
    Nath, Sarmila
    Chatterjee, R. N.
    Bhattacharjee, Sipra
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 : S9 - S9
  • [35] Utilisation and Safety of Deferasirox (Exjade®) in Older Adults: Results form a Post Authorisation Safety Study (PASS)
    Dhanda, Sandeep
    Layton, Deborah
    Osborne, Vicki
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 312 - 313
  • [36] Effectiveness and safety of empagliflozin in routine care: Results from the empagliflozin comparative effectiveness and safety (emprise) study
    Htoo, Phyo
    Tesfaye, Helen
    Paik, Julie
    Wexler, Deborah
    Najafzadeh, Mehdi
    Glynn, Robert
    Deruaz-Luyet, Anouk
    Farsani, Soulmaz
    Koeneman, Lisette
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 40 - 41
  • [37] Effectiveness and Safety of Empagliflozin in Routine Care: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Htoo, Phyo T.
    Tesfaye, Helen
    Paik, Julie M.
    Wexler, Deborah J.
    Najafzadeh, Mehdi
    Glynn, Robert
    Deruaz-Luyet, Anouk
    Farsani, Soulmaz F. Fazeli
    Koeneman, Lisette
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [38] Utilisation and safety of low molecular weight heparins -: Prospective observational study in medical inpatients
    Cestac, P
    Bagheri, H
    Lapeyre-Mestre, M
    Sié, P
    Fouladi, A
    Maupas, E
    Léger, P
    Fontan, B
    Massip, P
    Montastruc, JL
    DRUG SAFETY, 2003, 26 (03) : 197 - 207
  • [39] Long-term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow-up for 52 weeks (P06125)-Secondary publication
    Kinoshita, Toshihiko
    Takekita, Yoshiteru
    Hiraoka, Shuichi
    Tamura, Fumihiro
    Iwama, Yasuhiro
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2023, 43 (03) : 328 - 337
  • [40] An evaluation of patient safety culture in a secondary care setting in Kuwait
    Alqattan, Hamad
    Cleland, Jennifer
    Morrison, Zoe
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2018, 13 (03): : 272 - 280
12345